TY - JOUR
T1 - Endogenous Endophthalmitis in Patients with MRSA Septicemia
T2 - A Case Series and Review of Literature
AU - Shenoy, Shailaja Bhat
AU - Thotakura, Meena
AU - Kamath, Yogish
AU - Bekur, Ragini
N1 - Publisher Copyright:
© 2016 Taylor & Francis Group, LLC.
PY - 2016/9/2
Y1 - 2016/9/2
N2 - Purpose: To report the presentation, predisposing factors, clinical features and outcome in 6 eyes of 3 patients with endogenous endophthalmitis secondary to methicillin resistant staphylococcus aureus (MRSA) septicaemia. Methods: Retrospective review of case records of 3 patients who were treated for endogenous endophthalmitis secondary to MRSA septicaemia in a tertiary referral institution. Results: All three patients had systemic predisposition to endogenous endophthalmitis (diabetes, urosepsis). Two patients presented within 1 week of onset of visual symptoms and the third after 3 months. Blood culture was positive for MRSA in all patients. Visual and anatomical improvement was noted in two patients who presented early. The third patient’s visual outcome despite early treatment with intravitreal antibiotics and vitrectomy was not satisfactory. Conclusion: Endogenous endophthalmitis by MRSA is a rare but serious condition. Early and specific therapy based on reliable detection of the underlying microorganism is needed for good anatomical and functional outcome.
AB - Purpose: To report the presentation, predisposing factors, clinical features and outcome in 6 eyes of 3 patients with endogenous endophthalmitis secondary to methicillin resistant staphylococcus aureus (MRSA) septicaemia. Methods: Retrospective review of case records of 3 patients who were treated for endogenous endophthalmitis secondary to MRSA septicaemia in a tertiary referral institution. Results: All three patients had systemic predisposition to endogenous endophthalmitis (diabetes, urosepsis). Two patients presented within 1 week of onset of visual symptoms and the third after 3 months. Blood culture was positive for MRSA in all patients. Visual and anatomical improvement was noted in two patients who presented early. The third patient’s visual outcome despite early treatment with intravitreal antibiotics and vitrectomy was not satisfactory. Conclusion: Endogenous endophthalmitis by MRSA is a rare but serious condition. Early and specific therapy based on reliable detection of the underlying microorganism is needed for good anatomical and functional outcome.
UR - http://www.scopus.com/inward/record.url?scp=84939530770&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84939530770&partnerID=8YFLogxK
U2 - 10.3109/09273948.2015.1020173
DO - 10.3109/09273948.2015.1020173
M3 - Article
C2 - 26222985
AN - SCOPUS:84939530770
SN - 0927-3948
VL - 24
SP - 515
EP - 520
JO - Ocular Immunology and Inflammation
JF - Ocular Immunology and Inflammation
IS - 5
ER -